APA (7th ed.) Citation

CS, S., P, C., FA, L., DS, S., M, D. T., J, S., . . . R, B. (2020). Pan-cancer population pharmacokinetics and exposure-safety and -efficacy analyses of atezolizumab in patients with high tumor mutational burden. Pharmacology research & perspectives, 8(6), e00685. https://doi.org/10.1002/prp2.685

Chicago Style (17th ed.) Citation

CS, Shemesh, et al. "Pan-cancer Population Pharmacokinetics and Exposure-safety and -efficacy Analyses of Atezolizumab in Patients with High Tumor Mutational Burden." Pharmacology Research & Perspectives 8, no. 6 (2020): e00685. https://doi.org/10.1002/prp2.685.

MLA (9th ed.) Citation

CS, Shemesh, et al. "Pan-cancer Population Pharmacokinetics and Exposure-safety and -efficacy Analyses of Atezolizumab in Patients with High Tumor Mutational Burden." Pharmacology Research & Perspectives, vol. 8, no. 6, 2020, p. e00685, https://doi.org/10.1002/prp2.685.